Are plasma renin activity and aldosterone levels useful as a screening test to differentiate between unilateral and bilateral renal artery stenosis in hypertensive patients?

Journal of Hypertension

Volumn 28, Issue 3, 2010, Pages 594-601

  Kotliar, Carol ^a   Inserra, Felipe ^a   Forcada, Pedro ^a   Cavanagh, Elena ^a   Obregon, Sebastián ^a   Navari, Carlos ^a   Castellaro, Carlos ^a   Sánchez, Ramiro ^b,c  

^a UNIVERSIDAD AUSTRAL   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c FAVALORO UNIVERSITY   (Argentina)

Author keywords

Bilateral renal arteries stenosis; Plasma renin activity; Renovascular disease; Serum aldosterone level; Unilateral renal artery stenosis

Indexed keywords

ALDOSTERONE; GADOLINIUM;

ALDOSTERONE BLOOD LEVEL; ARTERIOGRAPHY; ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; IMPLANTATION; KIDNEY ARTERY STENOSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STENT;

EID: 77149133084     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833487d4     Document Type: Article

References (32)

1. Goldblatt PJ. The Goldblatt experiment: a conceptual paradigm. In: Laragh JH, Brenner BM, editors. Hypertension: Pathophysiology, diagnosis and management. New York: Raven; 1995. pp. 23-35.
2. Guan S, Fox J, Mitchell KD, Navar LG. Angiotensin and angiotenin converting enzyme tissue levels in two-kidney, one clip hypertensive rats. Hypertension 1992; 20:763-767.
3. Huang W, Navar LG. Angiotensin mediated alterations in nephron function in Golblatt hypertensive rats. Am J Physiol 1982; 243 (renal fluid electrolyte physiol) 12:F553-F560.
4. Rimmer JM, Gennari J. Atherosclerotic renovascular disease. Ann Intern Med 1993; 118:712-719.
5. Dillon MJ, Ryness JM. Plasma renin activity and aldosterone concentration in children. BMJ 1975; 4:316-319.
6. Maxwell MH, Lupu AN, Viskoper RJ, Aravena LA, Waks UA. Mechanisms of hypertension during the acute and intermediate phases of the one-clip, two-kidney model in the dog. Circ Res 1977; 40 (5 Suppl 1):I24-I28.
7. McAreavey D, Brown JJ, Cumming AM, Davies DL, Fraser R, Lever AF, et al. Inverse relation of exchangeable sodium and blood pressure in hypertensive patients with renal artery stenosis. J Hypertens 1983; 1:297-302. (Pubitemid 14161955)
8. Takabatake T, Ohta H, Yamamoto Y, Ishida Y, Hara H, Ushiogi Y, et al. Effect of angiotensin blockade and converting enzyme inhibition on renovascular hypertension: comparison between unilateral and bilateral renal artery stenosis. Angiology 1987; 38:434-439.
9. Pimenta E, Calhoun DA. Resistant hypertension and aldosteronism. Curr Hypertens Rep 2007; 9:353-359.
10. Mann SJ, Pickering TG. Diagnosing renovascular hypertension: state of the art: 1992. Ann Intern Med 1992; 117:845-853.
11. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 1991; 73:952-957.
12. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461-470.
13. Levey AS, Greene T, Kusek JW, Beck GL, MDRD Study Group.Asimplified equation to predict glomerular filtration rate from serum creatinine (abstract). J Am Soc Nephrol 2000; 11:155A.
14. American Heart Association Directions for the Renovascular Disease Reporting Studies. Circulation 2002; 106:1572-1585.
15. Wilson C, Byrom FB. The vicious cycle in chronic Bright's disease: experimental evidence from the hypertensive rat. QJM 19; 10:65-93.
16. Skøtt O, Uhrenholt TR, Schjerning J, Hansen PB, Rasmussen LE, Jensen BL. Rapid actions of aldosterone in vascular health and disease: friend or foe? Pharmacol Ther 2006; 111:495-507.
17. Brown NJ. Aldosterone and end-organ damage. Curr Opin Nephrol Hypertens 2005; 14:235-241.
18. Pickering TG. Renovascular hypertension: etiology and pathophysiology. Semin Nucl Med 1989; 19:79-88.
19. Martinez-Maldonado M. Pathophysiology of renovascular hypertension. Hypertension 1991; 17:707-719.
20. Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diabetes 2002; 110:80-85.
21. Tiu SC, Choi CH, Shek CC, NgYW, Chan FK, NgCM, Kong AP. The use of aldosterone-renin ratio as a diagnostic test for primary hyperaldosteronism and its test characteristics under different conditions of blood sampling. J Clin Endocrinol Metab 2005; 90:72-78.
22. Ramos F, Kotliar C, Wilcox C, et al. Renal function outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003; 63:276-282.
23. Funder JW, Carey RM, Fardella C, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93:3266-3268
24. Yamaguchi T, Naito Z, Stoner GD, Franco-Saenz R, Mulrow PJ. Role of the adrenal renin-angiotensin system on adrenocorticotropic hormone and potassium-stimulated aldosterone production by rat adrenal glomerulosa cells in monolayer culture. Hypertension 1990; 16:635-641.
25. Williams GH. Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev 2005; 10:7-13.
26. Navar LG, Nishiyama A. Why are angiotensin concentrations so high in the kidney? Curr Opin Nephrol Hypertens 2004; 13:107-115.
27. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann NY Aca Sci 2002; 970:89-1000.
28. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99:2537-2542.
29. DiBona GF. Neural control of the kidney: past, present, and future. Hypertension 2003; 41:621-624.
30. DiBona GF. Central angiotensin modulation of baroreflex control of renal sympathetic nerve activity in the rat: influence of dietary sodium. Acta Physiol Scand 2003; 177:285-289.
31. Loon NR, Wilcox CS. Mild metabolic alkalosis impairs the natriuretic response to bumetanide in normal human subjects. Clin Sci 1998; 94:287-292.
32. Takeda Y. Pleiotropic actions of aldosterone and the effects of eplerenone, a selective mineralocorticoid receptor antagonist. Hypertens Res 2004; 27:781-789.